QLT Aczone Clears FDA With Restricted Indication

Labeling calls for testing for glucose 6-phosphate dehydrogenase deficiency before initiating treatment with Aczone (dapsone); patients with the enzyme deficiency should be monitored with regular blood counts. Patients are also advised to consider other acne therapies.